← Back to Search

Amino Acid Supplement

Barley Lysine Availability for Healthy Subjects

N/A
Waitlist Available
Led By Glenda Courtney-Martin, PhD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy with no known clinical condition which would affect protein or AA metabolism, ex. Diabetes
Not on any medications that could affect protein or amino acid metabolism e.g. steroids
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 hrs
Awards & highlights

Study Summary

This trial assessed the effect of different cooking methods on the lysine availability of barley.

Who is the study for?
This trial is for healthy young men aged 18-40 with stable body weight, not on medication affecting protein metabolism like steroids. They must have no clinical conditions such as diabetes that affect protein or amino acid metabolism and no recent significant weight changes.Check my eligibility
What is being tested?
The study examines how the body uses lysine from barley, focusing on the impact of cooking methods on its availability. Barley's low lysine content affects protein synthesis, which is crucial for growth and bodily functions.See study design
What are the potential side effects?
Since this trial involves consuming barley prepared in different ways, side effects are minimal but may include potential allergic reactions to ingredients used in the study diets.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am healthy and do not have conditions like diabetes that affect protein metabolism.
Select...
I am not taking steroids or any drugs that affect protein in my body.
Select...
I am a man aged between 18 and 40.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 hrs
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 hrs for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Phenylalanine Oxidation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Meabolic Availabiliy of BarleyExperimental Treatment1 Intervention
Healthy adult men

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
686 Previous Clinical Trials
6,944,786 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,341 Previous Clinical Trials
26,452,706 Total Patients Enrolled
Glenda Courtney-Martin, PhDPrincipal InvestigatorAssociate Scientist
5 Previous Clinical Trials
159 Total Patients Enrolled

Media Library

Barley (Amino Acid Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT03907020 — N/A
Healthy Subjects Research Study Groups: Meabolic Availabiliy of Barley
Healthy Subjects Clinical Trial 2023: Barley Highlights & Side Effects. Trial Name: NCT03907020 — N/A
Barley (Amino Acid Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03907020 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently available for this clinical experiment?

"According to clinicaltrials.gov, this scientific inquiry is no longer accepting participants. The trial was initially advertised on August 1st 2023 and last edited October 24th 2022. Although this particular study has closed its doors for recruitment, there are 839 other active trials looking for volunteers at the moment."

Answered by AI

Is enrollment for this research project still open?

"This clinical trial seeks 7 volunteers of healthy stature aged between 18 and 40. Applicants must adhere to the following prerequisites: a stable body weight within 5 pounds in the last three months, no medications that could interfere with protein or amino acid metabolism (such as steroids), maleness, an absence of any conditions which may hinder protein/amino acid metabolism such as diabetes."

Answered by AI

Is the current research protocol open to participants aged 75 and above?

"This medical research is exclusively looking for participants aged 18 to 40 years old."

Answered by AI
~5 spots leftby May 2027